A new trading day began on Monday, with Transmedics Group Inc (NASDAQ: TMDX) stock price down -3.13% from the previous day of trading, before settling in for the closing price of $175.66. TMDX’s price has ranged from $36.42 to $177.37 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 95.07%. Meanwhile, its annual earnings per share averaged 264.15%. With a float of $32.20 million, this company’s outstanding shares have now reached $32.67 million.
The extent of productivity of a business whose workforce counts for 584 workers is very important to gauge. In terms of profitability, gross margin is 60.66%, operating margin of -0.22%, and the pretax margin is 0.41%.
Transmedics Group Inc (TMDX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Transmedics Group Inc is 3.48%, while institutional ownership is 102.84%. The most recent insider transaction that took place on Aug 22 ’24, was worth 4,375,000. In this transaction President & CEO of this company sold 25,000 shares at a rate of $175.00, taking the stock ownership to the 61,643 shares. Before that another transaction happened on Aug 21 ’24, when Company’s President & CEO sold 20,000 for $171.03, making the entire transaction worth $3,420,600. This insider now owns 61,643 shares in total.
Transmedics Group Inc (TMDX) Latest Financial update
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.78 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 264.15% per share during the next fiscal year.
Transmedics Group Inc (NASDAQ: TMDX) Trading Performance Indicators
Here are Transmedics Group Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.04, a number that is poised to hit 0.29 in the next quarter and is forecasted to reach 1.85 in one year’s time.
Technical Analysis of Transmedics Group Inc (TMDX)
The latest stats from [Transmedics Group Inc, TMDX] show that its last 5-days average volume of 0.64 million was inferior to 0.76 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 76.65%. Additionally, its Average True Range was 8.11.
During the past 100 days, Transmedics Group Inc’s (TMDX) raw stochastic average was set at 92.96%, which indicates a significant increase from 77.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.76% in the past 14 days, which was higher than the 59.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $151.87, while its 200-day Moving Average is $106.68. Now, the first resistance to watch is $174.83. This is followed by the second major resistance level at $179.50. The third major resistance level sits at $182.41. If the price goes on to break the first support level at $167.25, it is likely to go to the next support level at $164.34. The third support level lies at $159.67 if the price breaches the second support level.
Transmedics Group Inc (NASDAQ: TMDX) Key Stats
With a market capitalization of 5.68 billion, the company has a total of 32,937K Shares Outstanding. Currently, annual sales are 241,620 K while annual income is -25,030 K. The company’s previous quarter sales were 114,310 K while its latest quarter income was 12,190 K.
